Date Name Title Filing Type Shares Traded Price Total Held
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 200 -- 448
Jul 27, 2009
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Open market or private sale of non-derivative or derivative security 2,200 $21.02 350
Jul 24, 2009
SVP Res and Dev Sciences
SVP Res and Dev Sciences Form 4 Open market or private sale of non-derivative or derivative security 10,537 $20.00 350
Sep 30, 2008
SVP, Research & Devel Sciences
SVP, Research & Devel Sciences Form 4 Open market or private sale of non-derivative or derivative security 200 $21.53 350
Oct 31, 2006
SVP, Therap & Clin Prog Dev
SVP, Therap & Clin Prog Dev Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 400 -- 48
Feb 02, 2024
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,750 -- --
Aug 04, 2022
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 95,000 -- --
May 14, 2021
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 12,500 -- --
May 23, 2018
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 26,736 -- --
Jun 14, 2017
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,295 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.